Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba
Author(s) -
Miguel Galindo,
P Kouri,
Roland W. Sutter
Publication year - 2007
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa054960
Subject(s) - medicine , poliovirus , seroconversion , inactivated poliovirus vaccine , poliomyelitis , vaccination , diphtheria , pediatrics , population , randomized controlled trial , virology , hib vaccine , immunogenicity , immunology , virus , antibody , environmental health , conjugate vaccine
After poliomyelitis has been eradicated, access to live polioviruses will be highly restricted and the use of oral poliovirus vaccine (OPV) will probably be discontinued. Countries using OPV must decide whether to switch to inactivated poliovirus vaccine (IPV) or stop polio vaccination. Because data on the immunogenicity of IPV in tropical developing countries are limited, we conducted a randomized, controlled trial of IPV in Cuba.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom